(Q39478341)

12 September 2017

title

Persistent elevation of hepatocyte growth factor activator inhibitors in cholangiopathies affects liver fibrosis and differentiation (English)

1 reference

12 September 2017

Ming-Shyue Lee

17

0 references

Ya-Hui Chuang

Ya-Hui Chuang

12

0 references

Hsiang-Po Huang

Hsiang-Po Huang

1

0 references

Yao-Ming Wu

Yao-Ming Wu

7

0 references

Hong-Yuan Hsu

Hong-Yuan Hsu

4

0 references

Yung-Ming Jeng

Yung-Ming Jeng

14

0 references

author name string

Mei-Hwei Chang

2

1 reference

12 September 2017

Yi-Tzu Chen

3

1 reference

12 September 2017

Cheng-Lun Chiang

5

1 reference

12 September 2017

Tai-Shan Cheng

6

1 reference

12 September 2017

Mu Zon Wu

8

1 reference

12 September 2017

Yu-Chen Hsu

9

1 reference

12 September 2017

Chih-Che Shen

10

1 reference

12 September 2017

Chun-Nan Lee

11

1 reference

12 September 2017

Chia-Lun Hong

13

1 reference

12 September 2017

Pin-Hsun Chen

15

1 reference

12 September 2017

Huey-Ling Chen

16

1 reference

12 September 2017

language of work or name

English

0 references

publication date

16 November 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

55

1 reference

12 September 2017

issue

1

1 reference

12 September 2017

page(s)

161-172

1 reference

Extrahepatic biliary atresia: current concepts and future directions

12 September 2017

cites work

1 reference

21 January 2018

1 reference

Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2.

21 January 2018

1 reference

Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease

21 January 2018

1 reference

Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity

21 January 2018

1 reference

Simultaneous activation and hepatocyte growth factor activator inhibitor 1-mediated inhibition of matriptase induced at activation foci in human mammary epithelial cells.

21 January 2018

1 reference

Distribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues. Cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissues

21 January 2018

1 reference

Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta

21 January 2018

1 reference

Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice

21 January 2018

1 reference

Augmented expression of hepatocytes growth factor activator inhibitor type 1 (HAI-1) in intrahepatic small bile ducts in primary biliary cirrhosis.

21 January 2018

1 reference

Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers.

21 January 2018

1 reference

Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis

21 January 2018

1 reference

Human hepatic stem cell and maturational liver lineage biology.

21 January 2018

1 reference

Distortion in TGF beta 1 peptide immunolocalization in biliary atresia: comparison with the normal pattern in the developing human intrahepatic bile duct system.

21 January 2018

1 reference

Cyclooxygenase-2 overexpression is associated with clinical outcome in biliary atresia

21 January 2018

1 reference

Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia.

21 January 2018

1 reference

Cholangiocyte proliferation and liver fibrosis.

21 January 2018

1 reference

Altered expression of genes involved in hepatic morphogenesis and fibrogenesis are identified by cDNA microarray analysis in biliary atresia

21 January 2018

1 reference

Serine proteases, inhibitors and receptors in renal fibrosis.

21 January 2018

1 reference

7 January 2021

Defect of pro-hepatocyte growth factor activation by fibroblasts in idiopathic pulmonary fibrosis

1 reference

7 January 2021

The significance of serum hepatocyte growth factor levels in planning follow-up of postoperative jaundice-free patients with biliary atresia

1 reference

7 January 2021

Extrahepatic biliary atresia: a first-trimester event? Clues from light microscopy and immunohistochemistry

1 reference

7 January 2021

Immunolocalization of OV-6, a putative progenitor cell marker in human fetal and diseased pediatric liver

1 reference

7 January 2021

Hepatic tumor necrosis factors production and distant organ dysfunction in a murine model of obstructive jaundice

1 reference

7 January 2021

Long-term culture of hepatic progenitors derived from mouse Dlk+ hepatoblasts

1 reference

7 January 2021

Isolation of primary rat liver fibroblasts

1 reference

7 January 2021

Serotypic characterization of rotaviruses derived from asymptomatic human neonatal infections.

1 reference

7 January 2021

Levels of circulating antiinflammatory cytokine interleukin-1 receptor antagonist and proinflammatory cytokines at different stages of biliary atresia

1 reference

7 January 2021

Hepatic and serum bile acid compositions in patients with biliary atresia: a microanalysis using gas chromatography-mass spectrometry with negative ion chemical ionization detection

1 reference

7 January 2021

Expression of collagens type I and IV, osteonectin and transforming growth factor beta-1 (TGFbeta1) in biliary atresia and paucity of intrahepatic bile ducts during infancy

1 reference

7 January 2021

Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.24657

1 reference

12 September 2017

1 reference